Blt Skin Cream
NDC Package 73341-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Blt Skin Cream (benzocaine, lidocaine, tetracaine) cream is adults and children over 17 years of age:Apply to affected area of pain no more than 3-4 times per day. This formulation utilizes a cream delivery system. Marketed by M2b Pharma Llc, this product is identified by NDC 73341-001 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
73341-001-01
Package Description
454 g in 1 JAR
Product Code
73341-001
11-Digit Billing Format
73341000101
RxNorm Crosswalk
  • RxCUI: 2275621 - benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream
  • RxCUI: 2275621 - benzocaine 200 MG/ML / lidocaine 40 MG/ML / tetracaine 10 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Blt Skin Cream
Non-Proprietary Name
Benzocaine, Lidocaine, Tetracaine
Substance Name
Benzocaine; Lidocaine; Tetracaine
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children over 17 years of age:Apply to affected area of pain no more than 3-4 times per day. Do not cover with any occlusive dressingDo not use on children 17 years and younger without consulting a doctor.

Regulatory & Marketing

Labeler Name
M2b Pharma Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-04-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73341-001). Click a package code to view its specific billing and regulatory data.

73341-001-30
30 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73341-001-01 identifies a specific commercial package of 454 g in 1 jar of Blt Skin Cream, a human over the counter drug labeled by M2b Pharma Llc. This cream is formulated for topical use and contains benzocaine; lidocaine; tetracaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by M2b Pharma Llc on February 04, 2020. The current certification is valid through December 31, 2026.

How is this M2b Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73341000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73341-001-01
11-Digit CMS (5-4-2)
73341-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.